摘要 |
The present disclosure relates to the use of an antibody against interleukin-8 in the preparation of a medicament for treating Chronic Obstructive Pulmonary Disease (COPD) or any one of its indications, including for example, chronic bronchitis, emphysema, and irreversible asthma. The disclosure also provides methods of treating Chronic Obstructive Pulmonary Disease (COPD) and its various indications, particularly including chronic bronchitis, emphysema, and irreversible asthma. Treatment regimens generally include the administration of anti-interleukin-8 antibodies to the patient to reduce the severity of an inflammatory response by the patient's immune system.
|
申请人 |
ABGENIX, INC.;YANG, XIAO-DONG;BELL, GREGORY, M.;GLADUE, RONALD, P.;KUDLACZ, ELIZABETH, M.;SHOWELL, HENRY, J. |
发明人 |
YANG, XIAO-DONG;BELL, GREGORY, M.;GLADUE, RONALD, P.;KUDLACZ, ELIZABETH, M.;SHOWELL, HENRY, J. |